BioNTech SE announced that Sean Marett, Chief Business and Commercial Officer, will retire as planned from the Management Board of BioNTech.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
91.21 USD | -1.36% | -1.01% | -13.45% |
12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.45% | 22.31B | |
+9.42% | 115B | |
+13.07% | 107B | |
-3.49% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+7.56% | 14.26B | |
+34.66% | 12.37B | |
-26.67% | 8.28B | |
+18.63% | 8.26B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech SE Announces Retirement of Sean Marett as Chief Business and Commercial Officer